Pharma and Biotech
Form 8.3 - BENCHMARK HOLDINGS PLC | 05-Jun-2025 | 14:05 | RNS |
Form 8.3 - BENCHMARK HOLDINGS PLC | 04-Jun-2025 | 15:12 | RNS |
Form 8.3 - BENCHMARK HOLDINGS PLC | 03-Jun-2025 | 14:52 | RNS |
Form 8.3 - Benchmark Holdings Plc | 03-Jun-2025 | 14:23 | RNS |
Holding(s) in Company | 03-Jun-2025 | 12:48 | RNS |
Form 8.3 - Benchmark Holdings Plc | 02-Jun-2025 | 16:15 | RNS |
Form 8.3 - BENCHMARK HOLDINGS PLC | 02-Jun-2025 | 16:01 | RNS |
Rule 2.9 Announcement and Total Voting Rights | 02-Jun-2025 | 16:00 | RNS |
Form 8 (OPD) - Benchmark Holdings plc | 02-Jun-2025 | 13:00 | RNS |
Form 8 (OPD) - Benchmark Holdings plc | 02-Jun-2025 | 13:00 | RNS |
Form 8.3 - Benchmark Holdings Plc | 30-May-2025 | 12:15 | RNS |
Form 8.3 - BENCHMARK HOLDINGS PLC | 30-May-2025 | 08:45 | RNS |
Form 8.3 - BENCHMARK HOLDINGS PLC | 28-May-2025 | 12:38 | RNS |
Form 8.3 - BENCHMARK HOLDINGS PLC | 28-May-2025 | 11:06 | RNS |
Form 8.3 - Benchmark Holdings plc | 28-May-2025 | 10:49 | RNS |
Currency | UK Pounds |
Share Price | 24.00p |
Closing Price Change | 0.000p |
% Change | 0.00 % |
52 Week High | 46.00p |
52 Week Low | 18.00p |
Volume | 0 |
Shares Issued | 742.42m |
Beta | 0.01 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
CFO | Septima Maguire |
CEO | Trond Williksen |
Chair | Tripp Lane |
You are here: research